There is a parallel market for NAD+ that most longevity content ignores: vials of lyophilised powder sold "for research use only," at a fraction of what consumer products cost. This page explains what that market actually is, because the price difference is real and the reason behind it is the part nobody puts on the label.
The short version
Research-use-only (RUO) material is sold legally on the explicit basis that it is not for human consumption. It is cheap because it skips the testing, sterility assurance and oversight that make something fit to put in a person. If you are an ordinary reader comparing NAD+ options, this category is not a cheaper version of the others — it is a different thing being sold under different rules.
What "research use only" actually means
It is a legal classification, not a marketing flourish.
A vendor may lawfully sell a compound to laboratories for experimental work without it being approved for human use. The moment that vendor markets it for human consumption, it becomes an unapproved drug and the legal position changes completely. So the RUO label does two jobs at once: it describes the intended buyer, and it insulates the seller.
What follows from that is the important part. Because the product is not sold for human use, the requirements that exist to make something safe for human use do not apply to it.
Why the vials are so much cheaper
| Research-use-only | Compounded prescription | |
|---|---|---|
| Sold for | Laboratory use | A named individual |
| Sterility assurance | Not required, often not claimed | Prepared under sterile compounding standards |
| Endotoxin testing | Frequently absent or undisclosed | Part of the standard |
| Identity & potency oversight | Vendor's own claim | Pharmacy licensing and inspection |
| Who answers if it is wrong | Effectively nobody | A licensed pharmacy |
| Price | Substantially lower | Substantially higher |
Read that table as a single sentence: the price gap is the cost of the assurances, removed. That is not a scandal and it is not a loophole — it is the honest economics of selling a chemical to a laboratory rather than a medicine to a person.
About those purity numbers
Listings in this category almost always advertise a purity figure, commonly 99%, usually supported by a certificate of analysis. Three things are worth understanding about that number.
- Purity is not sterility. A compound can be 99% the molecule it claims to be and still carry bacterial contamination or endotoxins. These are separate tests answering separate questions, and the second one is the one that matters for anything injected.
- The certificate may be the vendor's own. An independent third-party assay and an in-house document can look similar on a product page. Check which one you are being shown.
- It describes a batch, not your vial. A certificate is a snapshot of a production run, and it says nothing about handling, storage or shipping after that point.
Who this market actually serves
Honestly: a mix. Genuine laboratory buyers, and a much larger group of experienced self-experimenters who understand the category, accept the risk knowingly, and are going to purchase regardless of what any website tells them.
If you are in that second group, you already know the trade you are making and you do not need this page to frame it for you. What is worth saying is that vendor selection is the one variable you still control, and that transparency about testing is the thing worth comparing between them.
If you want the injectable route properly
For most readers who arrive here because injectable NAD+ sounded appealing and the clinic pricing did not, the realistic answer is not a research vial. It is the prescription telehealth route, where a licensed prescriber reviews an intake and a compounding pharmacy dispenses to you. It costs more than a vial and considerably less than an infusion, and the assurances in the table above are included in that price.
If the appeal was mainly cost, oral capsules remain the cheapest route per dose by a wide margin, with the deepest human evidence behind them.
What we would need to change our minds
If a vendor in this category published routine third-party sterility and endotoxin testing per batch, the gap described on this page would narrow meaningfully, and we would say so. As it stands the distinction between research-grade and pharmacy-dispensed material is substantive rather than bureaucratic.
Related: Injectable NAD+ via prescription · IV infusion · All delivery formats